These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2072307)

  • 1. Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
    Au JL; Dalton JT; Wientjes MG
    J Pharmacol Exp Ther; 1991 Jul; 258(1):357-64. PubMed ID: 2072307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of significant absorption of antipyrine from urinary bladder of rats.
    Dalton JT; Harrington MD; Au JL
    J Pharmacol Exp Ther; 1992 Feb; 260(2):608-13. PubMed ID: 1738110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interstitial cystitis on drug absorption from urinary bladder.
    Gao X; Buffington CA; Au JL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):818-23. PubMed ID: 7965801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder wall penetration of intravesical mitomycin C in dogs.
    Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
    Yoshida D; Todo H; Hasegawa T; Sugibayashi K
    Int J Pharm; 2007 Jun; 337(1-2):142-7. PubMed ID: 17280809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine.
    Song D; Wientjes MG; Gan Y; Au JL
    Clin Cancer Res; 1997 Jun; 3(6):901-9. PubMed ID: 9815765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.
    Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I
    In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of mitomycin C in human bladder.
    Wientjes MG; Badalament RA; Wang RC; Hassan F; Au JL
    Cancer Res; 1993 Jul; 53(14):3314-20. PubMed ID: 8324743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 356():1-190. PubMed ID: 12695785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
    Kamuhabwa AA; Roskams T; Baert L; De Witte PA
    Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of intestinal mucosa with urothelium in rat augmented bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid.
    Baig M; Miocinovic R; Keck RW; Fynes EM; Strobel SL; Kropp KA; Selman SH
    J Urol; 2007 Sep; 178(3 Pt 1):1108-12. PubMed ID: 17644132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of salicylic acid in goats and cattle.
    Short CR; Hsieh LC; Malbrough MS; Barker SA; Neff-Davis CA; Davis LE; Koritz G; Bevill RF
    Am J Vet Res; 1990 Aug; 51(8):1267-70. PubMed ID: 2386326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of C.I. Disperse Blue 1 (A commercial dye containing approximately 50% 1,4,5,8-tetraaminoanthraquinone, and 20% water) (CAS No. 2475-45-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 May; 299():1-241. PubMed ID: 12748707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.